Armata Pharmaceuticals financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Stock Price

$2.7

2023-03-01

Market Capitalization

$98.7 M

2023-03-01

Revenue

$409 K

FY, 2014

CreditSafe score

Score changed on Mar 23, 2023

Premium Content

USD	FY, 2014	FY, 2015	FY, 2016	FY, 2017	FY, 2018	FY, 2019	FY, 2020	FY, 2021
Revenue	409.0K
General and administrative expense	6.9M	6.4M	8.4M	7.6M	5.7M	9.3M	8.0M	8.3M
Operating expense total	12.7M	10.4M	14.1M	10.5M	10.6M	19.1M	22.4M
EBIT	(14.1M)	(10.2M)	(23.4M)	(16.2M)	(12.5M)	(19.8M)	(21.6M)	(23.8M)
EBIT margin, %	-3449.9%
Interest income				6.0K		96.0K	28.0K	5.0K
Pre tax profit		(589.0K)	(19.4M)	(14.1M)	(12.4M)	(19.5M)	(22.2M)	(23.2M)
Income tax expense		(73.0K)	(556.0K)	(1.3M)	(328.0K)
Net Income	23.1M	(516.0K)	(18.8M)	(12.8M)	(12.1M)	(19.5M)	(22.2M)	(23.2M)